When medical professionals aren't trained on bleeding disorders, patients face critical delays in treatment, says columnist.

Malia Hall, 7, suffered a stroke at birth due to a rare bleeding disorder called Neonatal Alloimmune Thrombocytopenia, or NAIT.

Slipstream has co-authored a landmark study on Hereditary Hemorrhagic Telangiectasia (HHT), offering the most comprehensive ...

Our genes underlie all aspects of life, from our looks to how our cells behave. This includes diseases, as genetic changes ...

Pfizer recently announced positive results from the BASIS study, the global phase 3 trial evaluating Hympavzi in young adults ...

Hurricane preparedness can involve some extra considerations for those with hemophilia, says columnist Jennifer Lynne, who shares some tips.

Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, the U.S. drugmaker said on Thursday.

COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved ...

Hemab Therapeutics Presents Positive Clinical and Preclinical Data Across Bleeding Disorder Pipeline at ISTH 2025 Congress PR Newswire COPENHAGEN, Denmark and CAMBRIDGE, Mass., June 24, 2025 ...

Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects ...